Pinnacle Medicines is a biotechnology company developing oral peptide therapeutics using proprietary AI and physics-based discovery platforms.
The company focuses on creating orally bioavailable peptide drugs and advancing a pipeline toward clinical proof-of-concept studies.
Leadership & Board
Current Number of Employees23
Current LinkedIn Followers2,841
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$89M
Total Amount Raised$89M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$89M
Latest Funding Amount$89M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Pinnacle Medicines had 23 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
23Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Pinnacle Medicines had 2,841 followers as of October 5, 2026. The number of followers increased by 1 (0.04%) week-over-week.
2,841Latest Followers Count
1(0.04%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.